IMAX Co. (NYSE:IMAX - Free Report) - Analysts at Roth Capital cut their Q3 2025 earnings per share estimates for IMAX in a research note issued on Thursday, April 24th. Roth Capital analyst E. Handler now expects that the company will post earnings per share of $0.19 for the quarter, down from their prior estimate of $0.20. The consensus estimate for IMAX's current full-year earnings is $0.91 per share.
A number of other brokerages have also recently issued reports on IMAX. Macquarie upped their price objective on shares of IMAX from $30.00 to $32.00 and gave the stock an "outperform" rating in a report on Friday. Wells Fargo & Company lowered their price objective on IMAX from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Thursday. JPMorgan Chase & Co. cut their price objective on IMAX from $27.00 to $26.00 and set a "neutral" rating on the stock in a research note on Friday, April 11th. Benchmark reaffirmed a "buy" rating and set a $30.00 target price on shares of IMAX in a research report on Thursday, April 10th. Finally, Wedbush reissued an "outperform" rating and issued a $32.00 price target on shares of IMAX in a research report on Thursday, April 17th. One analyst has rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $30.56.
Read Our Latest Stock Analysis on IMAX
IMAX Stock Up 2.6 %
IMAX stock opened at $23.89 on Monday. The firm has a 50 day moving average of $24.70 and a two-hundred day moving average of $24.37. IMAX has a 12 month low of $14.94 and a 12 month high of $27.77. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 48.76, a P/E/G ratio of 1.49 and a beta of 0.91.
IMAX (NYSE:IMAX - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.14). The firm had revenue of $92.67 million during the quarter, compared to the consensus estimate of $104.08 million. IMAX had a net margin of 7.40% and a return on equity of 8.60%.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC grew its position in IMAX by 14.2% during the fourth quarter. FMR LLC now owns 4,508,583 shares of the company's stock worth $115,420,000 after buying an additional 558,940 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of IMAX by 36.9% in the 4th quarter. Ameriprise Financial Inc. now owns 1,823,516 shares of the company's stock worth $46,671,000 after acquiring an additional 491,172 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of IMAX during the 4th quarter worth approximately $9,143,000. Lord Abbett & CO. LLC bought a new stake in shares of IMAX during the third quarter valued at approximately $6,322,000. Finally, Pier Capital LLC raised its stake in shares of IMAX by 132.6% in the fourth quarter. Pier Capital LLC now owns 478,760 shares of the company's stock valued at $12,256,000 after purchasing an additional 272,949 shares in the last quarter. Institutional investors own 93.51% of the company's stock.
IMAX Company Profile
(
Get Free Report)
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
